comparemela.com
Home
Live Updates
Veracyte Diagnostics Platform - Breaking News
Pages:
Latest Breaking News On - Veracyte diagnostics platform - Page 5 : comparemela.com
Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform
Grew full-year revenue to between $358 million and $359 million, an increase of 21% Acquisition broadens Veracyte’s presence across the cancer care continuum .
United states
Marc stapley
Ezra sofer
Veracyte inc
Genomics inc
Fenwick west
Morgan stanley co
Unaudited financial results
Weinberg partners
Veracyte diagnostics platform
Annual report
Quarterly report
vimarsana © 2020. All Rights Reserved.